Kumar B Pabbisetty

Kinetic analysis of the binding of monomeric and dimeric ephrins to Eph receptors: Correlation to function in a growth cone collapse assay

Chen Li, D. Nikolov, J. Himanen, 2007, Protein science : a publication of the Protein Society.

Discovery of a Potent Parenterally Administered Factor XIa Inhibitor with Hydroxyquinolin-2(1H)-one as the P2' Moiety.

S. Sheriff, D. Seiffert, J. Bozarth, 2015, ACS Medicinal Chemistry Letters.

Discovery of Milvexian, a High-Affinity, Orally Bioavailable Inhibitor of Factor XIa in Clinical Studies for Antithrombotic Therapy.

Michael A. Galella, S. Sheriff, A. Mathur, 2021, Journal of medicinal chemistry.

Discovery of a High Affinity, Orally Bioavailable Macrocyclic FXIa Inhibitor with Antithrombotic Activity in Preclinical Species.

P. Lam, S. Sheriff, A. Mathur, 2020, Journal of medicinal chemistry.

Novel phenylalanine derived diamides as Factor XIa inhibitors.

P. Lam, P. Morin, D. Seiffert, 2016, Bioorganic & medicinal chemistry letters.

Chemoselective deprotection of N-Boc group in amino acids and peptides by bismuth(III) trichloride

Longqin Hu, Raghavendra S. Navath, Kumar B Pabbisetty, 2006 .